GleamWall
中文EN

ELUT ELUTIA INC.

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1708527 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.2%
TTM net income YoY305.5%
TTM EPS YoY233.3%
Revenue 3-yr CAGR-26.9%
Net income 3-yr CAGR—

Margins

Gross margin59.0%
Operating margin-279.0%
Net margin546.7%
FCF margin-509.4%
EBITDA margin-265.2%

Returns

ROE—
ROA140.2%
ROIC (approx.)—
Asset turnover0.26x

Leverage & solvency

Liabilities / assets68.2%
Debt / equity0.53x
Current ratio2.63x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.91x
Accruals ratio267.1%
Payout ratio—
Capex / revenue14.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$12.29M$14.47M
Cost of revenue$5.70M$7.75M
Gross profit$6.60M$6.71M
R&D expense$4.16M$3.00M
SG&A expense$15.08M$18.07M
Operating income-$26.91M-$30.71M
Interest expense—$4.78M
Pretax income-$15.86M-$45.34M
Income tax$13,000$7,000
Net income$53.38M-$53.95M
EBITDA-$24.13M-$27.26M
EPS (basic)1.29-1.86
EPS (diluted)0.87-1.86
Weighted avg. shares (diluted)45.94M29.07M
Balance sheet
Cash & equivalents$36.35M$13.24M
Receivables$1.73M$2.28M
Inventory$438,000$1.93M
Current assets$55.82M$26.17M
PP&E, net$2.51M$671,000
Intangibles$1.53M$2.60M
Total assets$62.35M$36.13M
Current liabilities$25.14M$37.80M
Short-term debt—$1.25M
Long-term debt—$22.60M
Total debt—$23.85M
Total liabilities$34.68M$82.39M
Shareholders' equity$27.67M-$46.26M
Net debt—$10.61M
Cash flow statement
Operating cash flow-$44.81M-$22.66M
Capital expenditure$1.88M$654,000
Free cash flow-$46.69M-$23.31M
Investing cash flow$78.56M-$474,000
Financing cash flow-$10.64M$17.09M
Depreciation & amortization$2.79M$3.45M
Stock-based compensation$5.21M$7.89M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.